Loading…

2015 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the Management of Hypertension

Abstract It has been almost 5 years since the publication of the 2010 hypertension guidelines of the Taiwan Society of Cardiology (TSOC). There is new evidence regarding the management of hypertension, including randomized controlled trials, non-randomized trials, post-hoc analyses, subgroup analyse...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the Chinese Medical Association 2015-01, Vol.78 (1), p.1-47
Main Authors: Chiang, Chern-En, Wang, Tzung-Dau, Ueng, Kwo-Chang, Lin, Tsung-Hsien, Yeh, Hung-I, Chen, Chung-Yin, Wu, Yih-Jer, Tsai, Wei-Chuan, Chao, Ting-Hsing, Chen, Chen-Huan, Chu, Pao-Hsien, Chao, Chia-Lun, Liu, Ping-Yen, Sung, Shih-Hsien, Cheng, Hao-Min, Wang, Kang-Ling, Li, Yi-Heng, Chiang, Fu-Tien, Chen, Jyh-Hong, Chen, Wen-Jone, Yeh, San-Jou, Lin, Shing-Jong
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract It has been almost 5 years since the publication of the 2010 hypertension guidelines of the Taiwan Society of Cardiology (TSOC). There is new evidence regarding the management of hypertension, including randomized controlled trials, non-randomized trials, post-hoc analyses, subgroup analyses, retrospective studies, cohort studies, and registries. More recently, the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC) published joint hypertension guidelines in 2013. The panel members who were appointed to the Eighth Joint National Committee (JNC) also published the 2014 JNC report. Blood pressure (BP) targets have been changed; in particular, such targets have been loosened in high risk patients. The Executive Board members of TSOC and the Taiwan Hypertension Society (THS) aimed to review updated information about the management of hypertension to publish an updated hypertension guideline in Taiwan. We recognized that hypertension is the most important risk factor for global disease burden. Management of hypertension is especially important in Asia where the prevalence rate grows faster than other parts of the world. In most countries in East Asia, stroke surpassed coronary heart disease (CHD) in causing premature death. A diagnostic algorithm was proposed, emphasizing the importance of home BP monitoring and ambulatory BP monitoring for better detection of night time hypertension, early morning hypertension, white-coat hypertension, and masked hypertension. We disagreed with the ESH/ESH joint hypertension guidelines suggestion to loosen BP targets to
ISSN:1726-4901
1728-7731
DOI:10.1016/j.jcma.2014.11.005